(Q35046541)

6 August 2017

1 reference

title

Treatment of hepatic fibrosis: almost there (English)

1 reference

6 August 2017

Efsevia Albanis

1

1 reference

PubMed ID

12530948

6 August 2017

Rifaat Safadi

series ordinal

2

1 reference

PubMed ID

12530948

6 August 2017

Scott L Friedman

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

Current gastroenterology reports

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

48-56

1 reference

6 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-003-0009-7

6 August 2017

0 references

cites work

Modulation of growth factor action: implications for the treatment of cardiovascular diseases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-003-0009-7

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

21 January 2018

1 reference

12 December 2020

Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing

1 reference

12 December 2020

Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair

1 reference

12 December 2020

A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats

1 reference

12 December 2020

Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells

1 reference

12 December 2020

Is liver fibrosis reversible?

1 reference

12 December 2020

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

12 December 2020

Effects and regulation of connective tissue growth factor on hepatic stellate cells.

1 reference

12 December 2020

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

1 reference

12 December 2020

Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis.

1 reference

12 December 2020

Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

1 reference

12 December 2020

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension

1 reference

12 December 2020

Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females.

1 reference

12 December 2020

ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Metals, oxidative stress, and hepatic fibrogenesis

1 reference

12 December 2020

Extracellular matrix degradation and the role of hepatic stellate cells

1 reference

12 December 2020

Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healing

1 reference

12 December 2020

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

12 December 2020

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

1 reference

12 December 2020

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

1 reference

12 December 2020

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

1 reference

12 December 2020

Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis

1 reference

12 December 2020

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

1 reference

12 December 2020

Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride.

1 reference

12 December 2020

Cytokine receptors and signaling in hepatic stellate cells

1 reference

12 December 2020

Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells

1 reference

12 December 2020

Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic blood flow regulation by stellate cells in normal and injured liver

1 reference

12 December 2020

In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation

1 reference

12 December 2020

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

12 December 2020

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

12 December 2020

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

12 December 2020

Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis

1 reference

12 December 2020

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

12 December 2020

Hepatic stellate cell behavior during resolution of liver injury

1 reference

12 December 2020

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

12 December 2020

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture

1 reference

12 December 2020

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

1 reference

12 December 2020

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy

1 reference

12 December 2020

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

1 reference

12 December 2020

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases in liver fibrosis

1 reference

12 December 2020

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

12 December 2020

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

12 December 2020

10.1007/S11894-003-0009-7

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12530948